Next |
home / stock / rexn / rexn message board
Subject | By | Source | When |
---|---|---|---|
11/06/2020: $REXN now re-brands with new ticker | saturn_five | investorshub | 11/06/2020 1:26:45 AM |
Following closing, which is expected to occur in | kpisme | investorshub | 08/28/2020 6:18:54 PM |
Does anybody know when the merger is suppose | geenback | investorshub | 08/27/2020 4:44:07 PM |
* * $REXN Video Chart 02-12-2020 * * | ClayTrader | investorshub | 02/12/2020 11:18:34 PM |
Total shares traded today 19.6 mill Thats almost 5x | ttubular | investorshub | 02/11/2020 11:14:28 PM |
* * $REXN Video Chart 02-11-2020 * * | ClayTrader | investorshub | 02/11/2020 10:42:52 PM |
$REXN 4.26 hi | TheFinalCD | investorshub | 02/11/2020 5:15:31 PM |
Over $4 | ttubular | investorshub | 02/11/2020 4:50:43 PM |
$3.60 :D | wesley_ | investorshub | 02/11/2020 4:10:07 PM |
$3.06 nice | wesley_ | investorshub | 02/11/2020 3:58:42 PM |
I am in outstanding 8-k! | powerbattles | investorshub | 02/11/2020 3:32:41 PM |
On February 8, 2020, Rexahn Pharmaceuticals, Inc. (the | ttubular | investorshub | 02/11/2020 4:09:22 AM |
Nice after hours pop in share price. Made | ttubular | investorshub | 02/10/2020 10:39:20 PM |
* * $REXN Video Chart 11-01-2019 * * | ClayTrader | investorshub | 11/01/2019 8:09:34 PM |
This companys pipeline has so much potential. Ive | Crozz | investorshub | 06/19/2019 6:51:06 PM |
Please update the ticker on this board to | Crozz | investorshub | 06/19/2019 6:42:07 PM |
Rexahn Announces Move to Nasdaq | Crozz | investorshub | 06/19/2019 6:37:57 PM |
Why move to NASDAQ right now? This is | Crozz | investorshub | 06/19/2019 6:30:43 PM |
News: $RNN Biotech Brief: Optimism Rising For Cancer | whytestocks | investorshub | 04/17/2019 12:31:07 PM |
Right?!? Love that last kick to the crotch | DorianGray | investorshub | 04/17/2019 3:25:04 AM |
News, Short Squeeze, Breakout and More Instantly...
Rexahn Pharmaceuticals Company Name:
REXN Stock Symbol:
NYSE Market:
FARMINGTON HILLS, Mich., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders, today announced that will participate in the H.C. Wainwrigh...
Merger completed with Rexahn Pharmace u ticals c reat ing a Nasdaq-listed Biopharmaceutical Company Focused on Advancing Ocuphire’s Late-Stage Clinical Pipeline of Ophthalmic Drug Candidates Trading under "OCUP" on the Nasdaq Capital Market to begin No...
ROCKVILLE, Md., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NASDAQ:REXN) (“Rexahn”) announced today that the merger transaction between Rexahn and Ocuphire Pharma, Inc. is expected to be effective shortly after 4:00 pm (EST) today, Thursday, November 5, 202...